Abbott Laboratories (ABT): I Am Very Upset With Abbott," Says Jim Cramer

We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed.

Abbott Laboratories (NYSE:ABT) is a healthcare company. While it was one of Cramer’s top stocks for most of this year, this show saw the CNBC TV host take a different tone. Abbott Laboratories (NYSE:ABT)’s shares fell by 8.5% in July after the firm’s latest earnings results saw it warn about a massive $1 billion hit in 2025 from tariffs. Here’s what Cramer said about the firm:

“I am very upset with Abbott. They’re on tonight. I have supported the company for years and years. It’s the diagnostic business. We’ll have Robert Ford on tonight, it’s not catastrophic because I like the company, long term. But, this is not, this was another thing that happened this morning that I found quite disturbing.

“[On low guidance] Diagnostic, China, uh yeah, so we can talk about that they have even more COVID testing issues, you don’t miss if you’re Abbott Labs.”

Previously, Cramer discussed Abbott Laboratories (NYSE:ABT)’s earnings before the release:

“Then one of my absolute favorite companies, medical device maker, Abbott Labs reports. And you know, I always like to tell you which companies tend to be misinterpreted in a negative way during the earnings season. Abbott’s a textbook example. It bothers me, but there are always sellers who claim to be disappointed. So, if you don’t own any Abbott, may I suggest that you wait to see the numbers, wait for the stock’s opening, wait for the sellers to appear. Patience is a virtue with ABT.”

While we acknowledge the potential of ABT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.